ProCE Banner Activity

Optimizing Care for South Asians With IBD: Q&A From a Patient and HCP Panel Discussion (in Urdu)

Clinical Thought

Experts and patient advocates answer questions about treatment strategies for South Asians with inflammatory bowel disease, patient perspectives on how to effectively approach culturally competent care, and enrollment on clinical trials.

Released: September 19, 2023

Share

Faculty

Tauseef Ali

Tauseef Ali, MD, FACG, AGAF

Medical Executive Director
SSM Health Crohn’s and Colitis Center
Oklahoma City, Oklahoma

Sabina Ali

Sabina Ali, MD

Clinical Professor
Department of Pediatrics/Pediatric Gastroenterology, Hepatology and Nutrition
University of California San Francisco
San Francisco, California

Tina Aswani-Omprakash

Tina Aswani-Omprakash, MPH

President and Co-Founder, South Asian IBD Alliance
Mount Sinai Department of Medicine
Dr. Henry D. Janowitz Division of Gastroenterology
New York, New York

Madhura Balasubramaniam

Madhura Balasubramaniam, MA

PhD Student
Department of Humanities and Social Sciences
Indian Institute of Technology Madras 
Chennai, Tamil Nadu, India 

Sumit Bhatia

Sumit Bhatia, MBBS, MD, DM

Senior Consultant 
Gastroenterology and Hepatology 
Paras Hospitals 
Gurgaon, Haryana, India 

Parakkal Deepak

Parakkal Deepak, MBBS, MS, FACG 

Vice-President, South Asian IBD Alliance
Director of Clinical and Translational Research
Associate Professor of Medicine 
Division of Gastroenterology
John T. Milliken Department of Medicine 
Washington University School of Medicine in St. Louis 
St. Louis, MO, USA

Neha D. Shah

Neha D. Shah, MPH, RD, CNSC, CHES

Senior Dietitian 
Colitis and Crohn's Disease Center 
University of California, San Francisco 
San Francisco, California 

Provided by

Provided by Clinical Care Options, LLC in partnership with the South Asian IBD Alliance.

ProCE Banner
ProCE Banner

Supporters

This activity is supported by independent educational grants from Bristol Myers Squibb, Hollister, Inc., Janssen Pharmaceutical Companies, Lilly and akeda Pharmaceuticals U.S.A., Inc

Bristol Myers Squibb

Hollister, Inc.

Janssen Pharmaceutical Companies

Lilly

Takeda Pharmaceuticals U.S.A., Inc.

Target Audience

The enduring activities are intended for US- and OUS-based gastroenterologists, gastroenterology nurse practitioners and physician associates/physician assistants, primary care providers, and other healthcare professionals treating patients with IBD.

Program Learning Goal

The goal of this activity is to improve the clinical knowledge and competence among gastroenterology HCPs regarding the culturally sensitive management of South Asian patients with IBD.

Disclosure

Program Director

Tauseef Ali, MD, FACG, AGAF

Medical Executive Director
SSM Health Crohn’s and Colitis Center
Oklahoma City, Oklahoma

Tauseef Ali, MD, FACG, AGAF: consultant/advisor/speaker: AbbVie, Bristol-Myers Squibb, Janssen, Takeda.

Tina Aswani-Omprakash, MPH

President and Co-Founder, South Asian IBD Alliance
Mount Sinai Department of Medicine
Dr. Henry D. Janowitz Division of Gastroenterology
New York, New York

Tina Aswani-Omprakash, MPH: consultant/advisor/speaker: AbbVie, Boehringer Ingelheim, Genentech/Roche, Hollister, Janssen, Pfizer, Takeda, Tillots.

Primary Author

Sabina Ali, MD

Clinical Professor
Department of Pediatrics/Pediatric Gastroenterology, Hepatology and Nutrition
University of California San Francisco
San Francisco, California

Sabina Ali, MD, has no relevant financial relationships to disclose.

Madhura Balasubramaniam, MA

PhD Student
Department of Humanities and Social Sciences
Indian Institute of Technology Madras 
Chennai, Tamil Nadu, India 

Madhura Balasubramaniam, MA, has no relevant financial relationships to disclose.

Sumit Bhatia, MBBS, MD, DM

Senior Consultant 
Gastroenterology and Hepatology 
Paras Hospitals 
Gurgaon, Haryana, India 

Sumit Bhatia, MD, DM: consultant/advisor/speaker: Dr. Reddy's, Ferring, Janssen India, MSN, Takeda India, Zydus.

Parakkal Deepak, MBBS, MS, FACG 

Vice-President, South Asian IBD Alliance
Director of Clinical and Translational Research
Associate Professor of Medicine 
Division of Gastroenterology
John T. Milliken Department of Medicine 
Washington University School of Medicine in St. Louis 
St. Louis, MO, USA

Parakkal Deepak, MBBS, MS, FACG: consultant/advisor/speaker: AbbVie, Bristol-Myers Squibb/Celgene, Fresenius, Kabi; researcher: AbbVie, Alimentiv, Boehringer Ingelheim, Bristol-Myers Squibb/Celgene, CorEvitas, Genentech Roche, Iterative Scopes, Janssen, Pfizer/Arena, Prometheus, Scipher, Takeda.

Neha D. Shah, MPH, RD, CNSC, CHES

Senior Dietitian 
Colitis and Crohn's Disease Center 
University of California, San Francisco 
San Francisco, California 

Neha D. Shah, MPH, RD, CNSC, CHES, has no relevant financial relationships to disclose.